open access

Vol 5, No 2 (2020)
Letter to the Editor
Published online: 2020-04-14
Get Citation

Nonsteroidal anti-inflammatory drugs (NSAIDs) in COVID-19 patient

Michal Paprocki1
DOI: 10.5603/DEMJ.a2020.0016
·
Disaster Emerg Med J 2020;5(2):108-109.
Affiliations
  1. Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland

open access

Vol 5, No 2 (2020)
LETTERS TO THE EDITOR
Published online: 2020-04-14

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

COVID-19, SARS-CoV-2, treatment; fever, nonsteroidal anti-inflammatory drugs, NSAIDs

About this article
Title

Nonsteroidal anti-inflammatory drugs (NSAIDs) in COVID-19 patient

Journal

Disaster and Emergency Medicine Journal

Issue

Vol 5, No 2 (2020)

Article type

Letter to the Editor

Pages

108-109

Published online

2020-04-14

DOI

10.5603/DEMJ.a2020.0016

Bibliographic record

Disaster Emerg Med J 2020;5(2):108-109.

Keywords

COVID-19
SARS-CoV-2
treatment
fever
nonsteroidal anti-inflammatory drugs
NSAIDs

Authors

Michal Paprocki

References (8)
  1. Smereka J, Szarpak L, Filipiak KJ. Modern medicine in COVID-19 era. Disaster Emerg Med J. ; 2020.
  2. Lake MA. What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond). 2020; 20(2): 124–127.
  3. Ruetzler K, Szarpak L, Filipiak KJ, et al. The COVID-19 pandemic — a view of the current state of the problem. Disaster Emerg Med J. ; 2020.
  4. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020; 8(4): e21.
  5. Liu Z, Xiao X, Wei X, et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020 [Epub ahead of print].
  6. Day M. Covid-19: European drugs agency to review safety of ibuprofen. BMJ. 2020; 368: m1168.
  7. Sodhi M, Etminan M. Safety of Ibuprofen in Patients with COVID-19; Causal or Confounded? Chest. 2020 [Epub ahead of print].
  8. Gupta R, Misra A. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc). Diabetes Metab Syndr. 2020 [Epub ahead of print]; 14(3): 251–254.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl